Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Heart failure is associated with mitochondrial dysfunction so that restoring or improving mitochondrial health is of therapeutic importance. Recently, reduction in NAD+ levels and NAD+-mediated deacetylase activity has been recognized as negative regulators of mitochondrial function. Using a cardiac specific KLF4 deficient mouse line that is sensitive to stress, we found mitochondrial protein hyperacetylation coupled with reduced Sirt3 and NAD+ levels in the heart before stress, suggesting that the KLF4-deficient heart is predisposed to NAD+-associated defects. Further, we demonstrated that short-term administration of Nicotinamide Mononucleotide (NMN) successfully protected the mutant mice from pressure overload-induced heart failure. Mechanically, we showed that NMN preserved mitochondrial ultrastructure, reduced ROS and prevented cell death in the heart. In cultured cardiomyocytes, NMN treatment significantly increased long-chain fatty acid oxidation despite no direct effect on pyruvate oxidation. Collectively, these results provide cogent evidence that hyperacetylation of mitochondrial proteins is critical in the pathogenesis of cardiac disease and that administration of NMN may serve as a promising therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., et al. (2010) · Nature · doi:10.1038/nature08778 · Cited by 1,687
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238 · cited 2×
“Pharmacologically, administration of NAD+ precursors, such as NMN and nicotinamide riboside (NR), could normalize the NADH/NAD + ratio, restore protein acetylation and boost metabolic function [36].”
BackgroundMitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.035 · Cited by 950 · cited 2×
“Of note, NAMPT-mediated protection requires Sirt3 and Sirt4, suggesting a mitochondrial acetylation-related mechanism [41].”
BackgroundMills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837 · cited 2×
“NAD+ also can activate Sirt1 leading to deacetylation and activation of PGC1α, the master regulator of metabolism and mitochondrial biogenesis [40].”
BackgroundHirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787 · cited 2×
“by overexpression of Sirt3, has been shown to enhance metabolism [25,35].”
BackgroundTumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS
Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K., Zhao, S., & Xiong, Y. (2011) · The EMBO Reports · doi:10.1038/embor.2011.65 · Cited by 572 · cited 1×
“Sirt3-mediated deacetylation activates SOD2, while acetylation of SOD2 impairs its function leading to ROS stress [21,43].”
BackgroundShimazu, T., Hirschey, M. D., Hua, L., Dittenhafer-Reed, K. E., Schwer, B., Lombard, D. B., Li, Y., Bunkenborg, J., Alt, F. W., Denu, J. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.003 · Cited by 484
Research works printed but not linked: 30
- Lopaschuk, 2010, Myocardial fatty acid metabolism in health and disease, Physiol. Rev., 90, 207, 10.1152/physrev.00015.2009 · DOI · Paper page
- Huss, 2005, Mitochondrial energy metabolism in heart failure: a question of balance, J. Clin. Invest., 115, 547, 10.1172/JCI24405 · doi:10.1172/jci24405 · Paper page
- Riehle, 2012, PGC-1 proteins and heart failure, Trends Cardiovasc. Med., 22, 98, 10.1016/j.tcm.2012.07.003 · DOI
- Schilling, 2011, The PGC-1 cascade as a therapeutic target for heart failure, J. Mol. Cell. Cardiol., 51, 578, 10.1016/j.yjmcc.2010.09.021 · DOI
- Aubert, 2013, Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart, Biochim. Biophys. Acta (BBA), 1833, 840, 10.1016/j.bbamcr.2012.08.015 · DOI
- den Boer, 2003, Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement, J. Pediatr., 142, 684, 10.1067/mpd.2003.231 · DOI
- Hock, 2009, Transcriptional control of mitochondrial biogenesis and function, Annu. Rev. Physiol., 71, 177, 10.1146/annurev.physiol.010908.163119 · DOI · Paper page
- Heggermont, 2016, Metabolic support for the heart: complementary therapy for heart failure?, Eur. J. Heart Fail., 18, 1420, 10.1002/ejhf.678 · DOI
- Neubauer, 2007, The failing heart--an engine out of fuel, N. Engl. J. Med., 356, 1140, 10.1056/NEJMra063052 · DOI · Paper page
- Lesnefsky, 2001, Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure, J. Mol. Cell. Cardiol., 33, 1065, 10.1006/jmcc.2001.1378 · DOI · Paper page
- Lee, 2016, Normalization of NAD+ redox balance as a therapy for heart failure, Circulation, 134, 883, 10.1161/CIRCULATIONAHA.116.022495 · DOI · Paper page
- Kris-Etherton, 2004, Nutrition Committee of the American Heart Association Council on nutrition, metabolism, antioxidant vitamin supplements and cardiovascular disease, Circulation, 110, 637, 10.1161/01.CIR.0000137822.39831.F1 · DOI · Paper page
- Yang, 2016, Mitochondrial sirtuin network reveals dynamic sirt3-dependent deacetylation in response to membrane depolarization, Cell, 167, 985, 10.1016/j.cell.2016.10.016 · DOI · Paper page
- Atkins, 2007, Role of Kruppel-like transcription factors in endothelial biology, Circ. Res., 100, 1686, 10.1161/01.RES.0000267856.00713.0a · DOI · Paper page
- Haldar, 2007, Kruppel-like Factors (KLFs) in muscle biology, J. Mol. Cell. Cardiol., 43, 1, 10.1016/j.yjmcc.2007.04.005 · DOI
- McConnell, 2010, Mammalian Kruppel-like factors in health and diseases, Physiol. Rev., 90, 1337, 10.1152/physrev.00058.2009 · DOI · Paper page
- Liao, 2010, Kruppel-like factor 4 regulates pressure-induced cardiac hypertrophy, J. Mol. Cell. Cardiol., 49, 334, 10.1016/j.yjmcc.2010.04.008 · DOI · Paper page
- Haldar, 2010, Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation, Sci. Transl. Med., 2, 26ra26, 10.1126/scitranslmed.3000502 · DOI · Paper page
- Liao, 2015, Kruppel-like factor 4 is critical for transcriptional control of cardiac mitochondrial homeostasis, J. Clin. Invest., 125, 3461, 10.1172/JCI79964 · DOI · Paper page
- Dikalova, 2017, Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension, Circ. Res., 121, 564, 10.1161/CIRCRESAHA.117.310933 · DOI · Paper page
- Bharathi, 2013, Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site, J. Biol. Chem., 288, 33837, 10.1074/jbc.M113.510354 · DOI · Paper page
- Hershberger, 2017, Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases, Nat. Rev. Nephrol., 13, 213, 10.1038/nrneph.2017.5 · DOI · Paper page
- Rosca, 2008, Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation, Cardiovasc. Res., 80, 30, 10.1093/cvr/cvn184 · DOI · Paper page
- Horton, 2016, Mitochondrial protein hyperacetylation in the failing heart, JCI Insight, 2
- Dittenhafer-Reed, 2015, SIRT3 mediates multi-tissue coupling for metabolic fuel switching, Cell Metab., 21, 637, 10.1016/j.cmet.2015.03.007 · DOI · Paper page
- Yu, 2012, SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status, J. Biol. Chem., 287, 14078, 10.1074/jbc.M112.355206 · DOI · Paper page
- Alrob, 2014, Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling, Cardiovasc. Res., 103, 485, 10.1093/cvr/cvu156 · DOI · Paper page
- Fukushima, 2016, Acetylation control of cardiac fatty acid beta-oxidation and energy metabolism in obesity, diabetes, and heart failure, Biochim. Biophys. Acta, 1862, 2211, 10.1016/j.bbadis.2016.07.020 · DOI
- Bernardi, 2015, The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection, J. Mol. Cell. Cardiol., 78, 100, 10.1016/j.yjmcc.2014.09.023 · DOI · Paper page
- Giordano, 2005, Oxygen, oxidative stress, hypoxia, and heart failure, J. Clin. Invest., 115, 500, 10.1172/JCI200524408 · DOI · Paper page
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Calcium Signaling and Reactive Oxygen Species in Mitochondria
Bertero, E., & Maack, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.310082 · Cited by 617
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 294
Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
Hwang, E., & Song, S. (2020) · Biomolecules · doi:10.3390/biom10050687 · Cited by 144
Alegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
Rahman, S. U., Qadeer, A., & Wu, Z. (2024) · Aging and disease · doi:10.14336/ad.2023.0519-1 · Cited by 34
Metadata
- Authors
- Zhang, R., Shen, Y., Zhou, L., Sangwung, P., Fujioka, H., Zhang, L., & Liao, X.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 112
- Pages
- 64-73
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2751396798
- Cited by
- 78
- References
- 15
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.